Sep 25, 2018

Atezolizumab for metastatic triple-negative breast cancer

The Lancet Oncology
Robert Stirrups

Abstract

No abstract listed.

  • References
  • Citations

References

  • We're still populating references for this paper, please check back later.
  • References
  • Citations

Citations

  • This paper may not have been cited yet.

Mentioned in this Paper

MPDL3280A
Monoclonal Antibodies
Monoclonal antibodies, antineoplastic
Microdosing Trials, Human
Triple Negative Breast Neoplasms
Neoplasm Metastasis
Disease Progression
Drug Administration Schedule

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Related Papers

La Revue du praticien
Anne Vincent-Salomon
International Journal of Breast Cancer
Quyen D ChuThelma Hurd
Clinical Journal of Oncology Nursing
Debra L Winkeljohn
© 2020 Meta ULC. All rights reserved